Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiemetics for Bowel Preparation
NCT04583111Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of domperidone and sulpiride in nausea ((none)) and Vomiting (3 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of the discomforts during bowel preparation. Status: unknown.
02
Drugs
domperidonesulpiride
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT04583111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04583111.